Free Open Access Medical Education and Member Benefits

The International Fluid Academy adheres to the FOAM principles for all website visitors: FREE Open Access Medical Education (#FOAMed #FOAMcc #FOAMus). The scientific information provided on the International Fluid Academy website is meant to complement and not replace any advice or information from a health professional.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.



This site has NO claims relating to the benefit or performance of a specific medical treatment, commercial product or service. The FOAM section of this website is regularly updated. Last modification by Adminstrator (Manu Malbrain) on March 5th 2017 at 10:00

You get full access to:

become a member

Sign up today as IFAD member (membership is FREE for lifetime) and take advantage of more benefits:

As a registered member you gain extra benefits in addition to FOAM

  • Reduced registration rates on future IFAD meetings
  • Reduced registration rates on future IFAD workshops
  • Access to Social Community and discussion forum
  • Reduced rates on webshop items (books, DVD’s, goodies)
  • Early access to new publications (PPT, PDF, video, photo)

Cheap adderall medication Progestins do not protect against sexually transmitted diseases, a risk factor for teenagers for more info visit Buybuprenorphine.org/adderall/.

Preview video presentations

Over 250 video presentations are available.

All video presentations

Preview powerpoint Slides

Over 250 slides are available.

All slides

full text papers

Over 250 papers are available.

All papers

Perioperative goal directed therapy using automated closed-loop fluid management: the future?

Perioperative goal directed therapy using automated closed-loop fluid management: the future?

Alexandre Joosten, Brenton Alexander, Amelie Delaporte, Marc Lilot, Joseph Rinehart, Maxime Cannesson

Read this paper

Social Media

  like us on Facebook

  follow us on Twitter

  join Discussion group

  join us on Linkedin

  newsletter sign up

  post on the blog